Osteopenia clinical trials
8 active trials name this condition. Describe your situation to see which ones you may be eligible for.
- Ridge Augmentation Using Allograft Particles Hydrated With or Without Recombinant Human Platelet-Derived Growth Factor
- Bisphosphonate Use to Mitigate Bone Loss Secondary to Bariatric Surgery
- Elucidating the Minimal Effective Dose of Prunes for Bone Health in Postmenopausal Women
- Veverimer to Decrease Net Acid Excretion and Bone Resorption in Adults With Osteopenia
- Bone, Exercise, Alendronate, and Caloric Restriction
- Skeletal Effects of Type 1 Diabetes on Low-Trauma Fracture Risk
- Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)
- Release Kinetics of rhBMP-2 Using E-PRF as an Autologous Carrier: An In Vitro Analysis
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Osteopenia” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.